These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 28527717)
1. Inhibition of the lateral habenular CaMKⅡ abolishes naloxone-precipitated conditioned place aversion in morphine-dependent mice. Wang J; Li M; Wang P; Zha Y; He Z; Li Z Neurosci Lett; 2017 Jul; 653():64-70. PubMed ID: 28527717 [TBL] [Abstract][Full Text] [Related]
2. Naloxone-induced conditioned place aversion score and extinction period are higher in C57BL/6J morphine-dependent mice than in Swiss: Role of HPA axis. Navarro-Zaragoza J; Martínez-Laorden E; Teruel-Fernández FJ; Gómez-Murcia V; Cánovas A; Milanés MV; Laorden ML; Almela P Pharmacol Biochem Behav; 2021 Feb; 201():173106. PubMed ID: 33444599 [TBL] [Abstract][Full Text] [Related]
3. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Azar MR; Jones BC; Schulteis G Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156 [TBL] [Abstract][Full Text] [Related]
4. Projections from lateral habenular to tail of ventral tegmental area contribute to inhibitory effect of stress on morphine-induced conditioned place preference. Lu YG; Wang L; Chen JL; Zhu J; Meng XY; You ZD; Yu WF Brain Res; 2019 Aug; 1717():35-43. PubMed ID: 30914248 [TBL] [Abstract][Full Text] [Related]
5. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982 [TBL] [Abstract][Full Text] [Related]
6. Adaptation in 5-HT Zuo W; Wu L; Mei Q; Zuo Q; Zhou Z; Fu R; Li W; Wu W; Matthew L; Ye JH Neuropharmacology; 2019 Nov; 158():107747. PubMed ID: 31445991 [TBL] [Abstract][Full Text] [Related]
7. Mu opioid receptors in the medial habenula contribute to naloxone aversion. Boulos LJ; Ben Hamida S; Bailly J; Maitra M; Ehrlich AT; Gavériaux-Ruff C; Darcq E; Kieffer BL Neuropsychopharmacology; 2020 Jan; 45(2):247-255. PubMed ID: 31005059 [TBL] [Abstract][Full Text] [Related]
8. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence. Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717 [TBL] [Abstract][Full Text] [Related]
9. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Stinus L; Cador M; Zorrilla EP; Koob GF Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444 [TBL] [Abstract][Full Text] [Related]
10. Cannabidiol attenuates the expression of conditioned place aversion induced by naloxone-precipitated morphine withdrawal through the activation of 5-HT1A receptors. Souza AJ; Guimarães FS; Gomes FV Behav Brain Res; 2023 Jul; 450():114504. PubMed ID: 37209879 [TBL] [Abstract][Full Text] [Related]
11. Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice. Shoblock JR; Maidment NT Neuropsychopharmacology; 2006 Jan; 31(1):171-7. PubMed ID: 15956992 [TBL] [Abstract][Full Text] [Related]
12. Maintenance of conditioned place preferences and aversion in C57BL6 mice: effects of repeated and drug state testing. Sakoori K; Murphy NP Behav Brain Res; 2005 May; 160(1):34-43. PubMed ID: 15836898 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Fan GH; Wang LZ; Qiu HC; Ma L; Pei G Mol Pharmacol; 1999 Jul; 56(1):39-45. PubMed ID: 10385682 [TBL] [Abstract][Full Text] [Related]
14. Development, extinction and reinstatement of morphine withdrawal-induced conditioned place aversion in rats. Li Y; Liu X; Chen H; Deng H; Xiang X; Chen H; Hao W Addict Biol; 2007 Sep; 12(3-4):470-7. PubMed ID: 17678507 [TBL] [Abstract][Full Text] [Related]
15. Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M Psychopharmacology (Berl); 2003 Oct; 170(1):80-8. PubMed ID: 12768272 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the amygdala and hippocampal calcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in rats. Lu L; Zeng S; Liu D; Ceng X Neurosci Lett; 2000 Sep; 291(3):191-5. PubMed ID: 10984639 [TBL] [Abstract][Full Text] [Related]
17. The involvement of CRF1 receptor within the basolateral amygdala and dentate gyrus in the naloxone-induced conditioned place aversion in morphine-dependent mice. Valero E; Gómez-Milanés I; Almela P; Ribeiro Do Couto B; Laorden ML; Milanés MV; Núñez C Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):102-114. PubMed ID: 29407532 [TBL] [Abstract][Full Text] [Related]
18. Genetic knockout of the G protein-coupled estrogen receptor 1 facilitates the acquisition of morphine-induced conditioned place preference and aversion in mice. Sun K; Wang F; Ma L; Ren X; Zhang C; Rong W; Sun T Biochem Biophys Res Commun; 2020 May; 525(4):1061-1067. PubMed ID: 32184017 [TBL] [Abstract][Full Text] [Related]
19. Sex differences between CRF1 receptor deficient mice following naloxone-precipitated morphine withdrawal in a conditioned place aversion paradigm: implication of HPA axis. García-Carmona JA; Baroja-Mazo A; Milanés MV; Laorden ML PLoS One; 2015; 10(4):e0121125. PubMed ID: 25830629 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of AMPA receptor and CaMKII activity in the lateral habenula reduces depressive-like behavior and alcohol intake in rats. Li J; Kang S; Fu R; Wu L; Wu W; Liu H; Gregor D; Zuo W; Bekker A; Ye JH Neuropharmacology; 2017 Nov; 126():108-120. PubMed ID: 28865912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]